Telesis Bio Inc (TBIO)
0.92
-0.05
(-5.15%)
USD |
OTCM |
Nov 14, 15:59
Telesis Bio Total Assets (Quarterly): 52.73M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 52.73M |
| March 31, 2024 | 63.33M |
| December 31, 2023 | 70.41M |
| September 30, 2023 | 105.03M |
| June 30, 2023 | 114.53M |
| March 31, 2023 | 89.16M |
| December 31, 2022 | 81.36M |
| September 30, 2022 | 88.14M |
| Date | Value |
|---|---|
| June 30, 2022 | 97.28M |
| March 31, 2022 | 111.13M |
| December 31, 2021 | 116.26M |
| September 30, 2021 | 124.49M |
| June 30, 2021 | 136.42M |
| March 31, 2021 | 31.32M |
| December 31, 2020 | 26.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
26.86M
Minimum
Dec 2020
136.42M
Maximum
Jun 2021
87.23M
Average
89.16M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Standard BioTools Inc | 681.54M |
| Ainos Inc | 31.37M |
| Zomedica Corp | 214.12M |
| LENSAR Inc | 62.02M |
| Intelligent Bio Solutions Inc | 11.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.78M |
| Shareholders Equity (Quarterly) | 9.946M |
| Debt to Equity Ratio | 0.5307 |
| Current Ratio | 1.891 |
| Net Debt Paydown Yield | 44.78% |